St. Louis Financial Planners Acquire New Stake in Abbott Laboratories

Asset management firm adds over $2.8 million in shares of healthcare giant

Mar. 21, 2026 at 10:39am

Got story updates? Submit your updates here. ›

St. Louis Financial Planners Asset Management LLC acquired a new stake of 22,399 shares in Abbott Laboratories (NYSE:ABT) during the fourth quarter, according to a recent SEC filing. The firm's new position in the healthcare product maker is valued at approximately $2.8 million.

Why it matters

This investment by a St. Louis-based asset management firm highlights ongoing institutional interest in Abbott Laboratories, a major player in the healthcare and medical device industries. The acquisition signals confidence in Abbott's long-term growth prospects.

The details

According to the filing, St. Louis Financial Planners Asset Management LLC added the new position in Abbott Laboratories during the fourth quarter of the previous year. The firm's 22,399 shares of ABT stock are valued at around $2.8 million based on the stock's closing price on the acquisition date.

  • The new stake was acquired during the fourth quarter of 2025.

The players

St. Louis Financial Planners Asset Management LLC

A St. Louis-based asset management firm that recently added a new position in Abbott Laboratories stock.

Abbott Laboratories

A global healthcare company that develops, manufactures, and markets a broad portfolio of medical products and services.

Got photos? Submit your photos here. ›

The takeaway

This investment by a St. Louis-based asset manager underscores the continued appeal of Abbott Laboratories as a healthcare industry leader, even as the stock has seen some recent volatility. The acquisition signals confidence in Abbott's long-term growth potential.